Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Livzon Lizhudele is a prominent subsidiary of the Livzon Pharmaceutical Group, based in Zhuhai, China. The company is primarily recognized for its leadership in the gastroenterology market, specifically through its flagship brand Lizhudele, which produces Bismuth Potassium Citrate. This product is a cornerstone treatment in China for gastric ulcers, chronic gastritis, and the eradication of Helicobacter pylori. Beyond its core bismuth-based products, the company manages a range of digestive health medications and maintains robust manufacturing capabilities. As a key commercial arm of its parent organization, Livzon Lizhudele focuses on the production and distribution of high-quality gastrointestinal therapies for the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lizhudele.